Inhibition of GCN5 decreases skeletal muscle fat metabolism during high fat diet feeding

Green, A.; Perras, B. L.; Zhang, H.; Katsyuba, E.; Haboush, A.; Nyarko, K. M.; Pandey, D. K.; Nik-Akhtar, A.; Ryu, D.; Menzies, K. J.; Auwerx, J.

doi:10.1101/2022.10.18.512735

bioRxiv · 10.1101/2022.10.18.512735

Inhibition of GCN5 decreases skeletal muscle fat metabolism during high fat diet feeding

Green, A.·Perras, B. L.·Zhang, H.·Katsyuba, E.·Haboush, A.·Nyarko, K. M.·Pandey, D. K.·Nik-Akhtar, A.·Ryu, D.·Menzies, K. J.·Auwerx, J.

View original source ↗Export metadata ↓

Abstract

IntroductionGCN5 (Kat2a) is a lysine acetyl transferase capable of acetylating and inhibiting PGC-1 activity. As such, it is described as a negative regulator of PGC-1 and subsequently restricts mitochondrial content. However, elimination of GCN5 in skeletal muscle does not increase mitochondrial content or alter lipid metabolism under normal metabolic conditions. GCN5 levels increase with high-fat diet (HFD) feeding in rodents. Additionally, the GCN5 homolog, PCAF, has previously been shown to also acetylate and inhibit PGC-1 and therefore may possibly compensate for loss of GCN5. ObjectiveThe objective of this study was to examine if with HFD feeding that elimination of GCN5 (Kat2a gene) from skeletal muscle would elicit improvements in mitochondrial and metabolic markers. MethodsSkeletal muscle specific GCN5 knockouts (Gcn5 skm-/-) were fed an HFD. Body composition, cardio-metabolic and physical fitness outcomes were monitored. Additionally, cultured myotubes were treated with a pan-GCN5/PCAF inhibitor and examined for changes in mitochondrial markers. ResultsElimination of skeletal muscle GCN5 did not alter body composition, tissue masses, energy intake, or energy expenditure measurements of mice fed an HFD. Furthermore, whole body glucose homeostasis and cardiac measurements were not altered. There were few differences in lipid metabolism genes, relatively more glucose oxidation versus Gcn5 skm+/+ (wildtype) mice, and a reduction in Pdk4 expression. Exercise capacity and mitochondrial content levels were not altered in Gcn5 skm-/- mice. Further, elimination of GCN5 in skeletal muscle increased Kat2b (PCAF) mRNA expression; however, inhibition of GCN5/PCAF bromodomains in cultured myotubes did not increase oxidative metabolism genes and decreased expression of some mitochondrial genes and Pdk4 mRNA. ConclusionsNeither elimination of GCN5, nor simultaneous inhibition of GCN5 and its homolog PCAF improved skeletal muscle mitochondrial content under normal or HFD-fed conditions. Despite this, GCN5 may play a role in regulating macronutrient preference by regulating Pdk4 content. Thus, HFD/macronutrient excess revealed novel roles of GCN5 in skeletal muscle. Highlights- Skeletal muscle specific elimination of Gcn5/Kat2a decreases fat oxidation without 1) preventing high-fat diet induced weight gain, 2) improving whole body glucose handling, or 3) improving skeletal muscle mitochondrial content. - Inhibition of the GCN5 and PCAF bromodomains and Gcn5 ablation decreases expression of Pdk4. - Expression of Kat2b increases with Gcn5 elimination in skeletal muscle. - Inhibition of the GCN5 and PCAF bromodomains do not result in increased skeletal muscle mitochondrial content.

Explore related subjects

physiology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Green, A., Perras, B. L., Zhang, H., Katsyuba, E., Haboush, A., Nyarko, K. M., Pandey, D. K., Nik-Akhtar, A., Ryu, D., Menzies, K. J., Auwerx, J.. 2022-10-21. Inhibition of GCN5 decreases skeletal muscle fat metabolism during high fat diet feeding. https://doi.org/10.1101/2022.10.18.512735

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The canine hair metabolome encodes age and coat exposure in over 700 dogs

Hair can be collected noninvasively and stored for years, making it a practical sample for studying physiology and environmental exposure. Yet the chemical information it carries in dogs remains largely unexplored. We profiled 782 banked hair samples from 700 Golden Retrievers by untargeted liquid chromatography-mass spectrometry, detecting 4,533 compound groups and revealing an unexpectedly rich chemical profile. Prominent signals reflected skin-surface and hair chemistry, including amino acids, peptides and urocanic acid, alongside surfactants, plasticizers and pesticides detectable despite washing. A signal annotated as imidacloprid distinguished dogs receiving topical products containing this insecticide from dogs receiving no flea or tick preventive (AUC 0.865). Hair chemistry also varied with age, most strongly between puppyhood and early adulthood. Oxidized lipids generally declined, whereas amino acids and peptides remained largely stable. A multivariate model estimated age with moderate accuracy (cross-validated r = 0.66) and assigned a higher age to the later sample in 64 of 75 repeatedly sampled dogs. Because age and collection date were strongly correlated, their effects could not be fully separated, although date-restricted analyses supported an age-related contribution. Together, these findings establish banked dog hair as a promising resource for studying chemical exposure and life-stage-associated changes in chemistry.

physiology↗

bioRxiv2026

Dietary Human HSP90 Promotes Longevity and Healthspan in Caenorhabditis elegans via a Multi-Branched Stress Signaling Pathway

The loss of proteostasis is one of the primary drivers of aging. Despite the important role of the molecular chaperone HSP90 in maintaining proteostasis, its systemic role in aging appears contradictory because its inhibitors can effectively extend lifespan across diverse species. This study showed that dietary HSP90 supplementation via Escherichia coli significantly extended lifespan and healthspan of Caenorhabditis elegans without fertility trade-offs. Exogenous HSP90 likely acts as an extracellular signaling ligand that engages downstream kinase networks to drive the activation of three major longevity-associated transcription factors: DAF-16, SKN-1, and HSF-1. In addition, we demonstrated the additive effect of combining dietary HSP90 supplementation with the senolytic HSP90 inhibitor tanespimycin, indicating that extracellular proteostatic signaling and the intracellular inhibition of HSP90 can work together to enhance longevity. Finally, we engineered an antibiotic-free E. coli Nissle 1917 probiotic that constitutively expresses HSP90, which successfully extended the lifespan of C. elegans.

physiology↗

bioRxiv2026

Sex differences in myocardial ketone oxidation capacity in cardiometabolic disease with coincident ischemic heart disease

Background: Myocardial infarction (MI) in patients with heart failure with preserved ejection fraction (HFpEF) is associated with worse outcomes than MI in individuals without HFpEF. However, the molecular mechanisms underlying this increased vulnerability remain poorly understood. We investigated sex differences in cardiac ketone body (KB) metabolism in patients with diabetes-associated ischemic heart disease, and in a mouse model of HFpEF complicated by MI (HFpEF-MI). Methods: Cardiac BDH1 and OXCT1 expression was assessed in male and female patients with diabetes, with or without ischemic heart disease. Male and female mice received a high-fat diet and L-NAME for 10 weeks to induce HFpEF, followed by coronary artery ligation to induce MI. Glucose tolerance, cardiac function, survival, cardiac KB oxidative capacity, and circulating KB levels were evaluated. Results: Cardiac BDH1 and OXCT1 abundance was significantly reduced in male patients with diabetes-associated ischemic heart disease but preserved in female patients. In mice, 10 weeks of high-fat diet and L-NAME administration increased fasting blood glucose and impaired glucose tolerance. MI reduced systolic function in control and HFpEF mice of both sexes. Male HFpEF-MI mice exhibited higher mortality than female HFpEF-MI mice. Consistent with our human results, male HFpEF-MI mice showed reduced cardiac ketolytic enzyme expression alongside elevated circulating KB levels, whereas female mice maintained cardiac KB oxidative capacity. Conclusion: Reduced cardiac ketolytic enzyme expression and impaired KB oxidative capacity are associated with greater mortality in male HFpEF-MI mice, whereas female mice exhibit preserved KB oxidative capacity and improved survival. Similar sex differences in ketolytic enzyme expression were observed in patients with diabetes-associated ischemic heart disease. These findings identify cardiac ketone metabolism as a potential therapeutic target warranting further investigation in HFpEF complicated by MI.

physiology↗